ReviewHerzschrittmachertherapie & Elektrophysiologie2025
The present and future of cardiological telemonitoring in Europe: a statement from seven European countries.
Review in Herzschrittmachertherapie & Elektrophysiologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Telecardiology Activities in Hospital and University Cardiology Facilities in Italy: Survey Study.JMIR cardio · 2025Article
- [Telemedicine in chronic heart failure].Innere Medizin (Heidelberg, Germany) · 2025Article
- EHRA perspective on the digital data revolution in arrhythmia management: insights from the association's annual summit.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases remain one of the leading causes of death worldwide, placing a significant burden on individuals, families and healthcare systems. Telemedicine, in particular remote monitoring of patients with cardiovascular diseases, reduces this burden as it links the continuous monitoring of the health status with individual education and adaptation of the therapy to the needs of the patients. This improves patient outcomes and facilitates access to specialised healthcare services, independent of time and distance. Furthermore, telemedicine enables improvements in efficiency and promotes patients' self-care. However, the widespread adoption of remote patient monitoring faces several hurdles. A round table of experts from seven European countries (France, Germany, Italy, Poland, Spain, the Netherlands and the United Kingdom) reviewed the current state of telemedicine within the participating countries in order to learn from each other with an impetus for European co-operation. The creation of reliable regulations, overcoming regional differences, the redefinition of roles and processes, the personalisation of healthcare services, the promotion of innovation and research, the use of artificial intelligence and, finally, the efficient management and safeguarding of healthcare data were identified as key levers for further development of telemedicine. This discussion paper emphasises the need for cross-national research activities, involving all stakeholders, such as researchers, industry and patients, to foster the integration of telemedicine in clinical pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.